Pharmaceutical Exports of Iran in OIC Region and Entering International Markets
,
Abstract
There are various pharmaceutical companies in Iran with high potential. Due to the lack of business with international markets for exports, Iranian pharmaceutical products are mostly traded in domestic markets. Despite numerous studies on pharmaceutical exports in the literature, the performance of Iran in pharmaceutical exports to the Organization of Islamic Cooperation (OIC), remains yet to be evaluated. The novelty of the present work lies in filling this research gap and helping develop policies to expand pharmaceutical exports to Iran.
[1] Akhtar, G., Indian pharmaceutical industry: an overview. IOSR journal of Humanities and Social Science, 2013. 13(3): p. 51-66.
[2] https://www.oic-oci.org/page/?p_id=52&p_ref=26&lan=en.
[3] Radmanesh, R. and N.H. Naeini, Investigating and Ranking of Barriers Affecting Development of Pharmaceutical Industry Exports in Iran: AHP Method. Journal of Pharmacoeconomics and Pharmaceutical Management, 2023. 9(1): p. 9-13.
[4] COOPERATION, O.O.I., PHARMACEUTICAL INDUSTRY.
[5] Elasrag, H., Halal industry: Key challenges and opportunities. 2016.
[6] Piroozi, F., et al., Critical Success Factors in Strategic Alliances in Iran's Pharmaceutical Industry: A Qualitative Content Analysis Study. International Journal of Business Administration, 2022. 13(6).
[7] Hafner, T. and D. Popp, China and India as suppliers of affordable medicines to developing countries. 2011, National Bureau of Economic Research.
[8] Masoumi, M., et al., Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study. BMC Health Services Research, 2019. 19(1): p. 1-13.
[9] Cheraghali, A.M., Trends in Iran pharmaceutical market. Iranian journal of pharmaceutical research: IJPR, 2017. 16(1): p. 1.
[10] Shabaninejad, H., et al., The structure of the world pharmaceutical market: Prioritizing Iran’s target export markets. Iranian journal of pharmaceutical research: IJPR, 2019. 18(1): p. 546.
[11] Shoujaei, P., Review of drug exports rules and regulations of Iran and comparison to other OIC member states, in Iran University of Medical Sciences. 2017. p. pp. 56-59 (in persian).
[12] Mohammadzadeh, M., M. Poloee, and T. Ghari, Export readiness assessment of ten Iranian pharmaceutical companies and comparison with their export performance. 2016.
[13] Yang, Y., R.A. Monserud, and S. Huang, An evaluation of diagnostic tests and their roles in validating forest biometric models. Canadian Journal of Forest Research, 2004. 34(3): p. 619-629.
[14] Paeleman, I., C. Fuss, and T. Vanacker, Untangling the multiple effects of slack resources on firms’ exporting behavior. Journal of World Business, 2017. 52(6): p. 769-781.
[15] https://www.trademap.org/Country_SelProduct_TS
[16] Hassan, M.K., B.A. Sanchez, and M.E. Hussain, Economic performance of the OIC countries and the prospect of an Islamic common market. Journal of Economic Cooperation and Development, 2010. 31(2): p. 65-121.
[2] https://www.oic-oci.org/page/?p_id=52&p_ref=26&lan=en.
[3] Radmanesh, R. and N.H. Naeini, Investigating and Ranking of Barriers Affecting Development of Pharmaceutical Industry Exports in Iran: AHP Method. Journal of Pharmacoeconomics and Pharmaceutical Management, 2023. 9(1): p. 9-13.
[4] COOPERATION, O.O.I., PHARMACEUTICAL INDUSTRY.
[5] Elasrag, H., Halal industry: Key challenges and opportunities. 2016.
[6] Piroozi, F., et al., Critical Success Factors in Strategic Alliances in Iran's Pharmaceutical Industry: A Qualitative Content Analysis Study. International Journal of Business Administration, 2022. 13(6).
[7] Hafner, T. and D. Popp, China and India as suppliers of affordable medicines to developing countries. 2011, National Bureau of Economic Research.
[8] Masoumi, M., et al., Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study. BMC Health Services Research, 2019. 19(1): p. 1-13.
[9] Cheraghali, A.M., Trends in Iran pharmaceutical market. Iranian journal of pharmaceutical research: IJPR, 2017. 16(1): p. 1.
[10] Shabaninejad, H., et al., The structure of the world pharmaceutical market: Prioritizing Iran’s target export markets. Iranian journal of pharmaceutical research: IJPR, 2019. 18(1): p. 546.
[11] Shoujaei, P., Review of drug exports rules and regulations of Iran and comparison to other OIC member states, in Iran University of Medical Sciences. 2017. p. pp. 56-59 (in persian).
[12] Mohammadzadeh, M., M. Poloee, and T. Ghari, Export readiness assessment of ten Iranian pharmaceutical companies and comparison with their export performance. 2016.
[13] Yang, Y., R.A. Monserud, and S. Huang, An evaluation of diagnostic tests and their roles in validating forest biometric models. Canadian Journal of Forest Research, 2004. 34(3): p. 619-629.
[14] Paeleman, I., C. Fuss, and T. Vanacker, Untangling the multiple effects of slack resources on firms’ exporting behavior. Journal of World Business, 2017. 52(6): p. 769-781.
[15] https://www.trademap.org/Country_SelProduct_TS
[16] Hassan, M.K., B.A. Sanchez, and M.E. Hussain, Economic performance of the OIC countries and the prospect of an Islamic common market. Journal of Economic Cooperation and Development, 2010. 31(2): p. 65-121.
| Files | ||
| Issue | Vol 9 No 3 (2023) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/jppm.v9i3.14193 | |
| Keywords | ||
| Pharmaceutical industry performance, OIC Region, Pharmaceutical exports, Regulatory framework, Iran exports, Export market diversification, Medicine products | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Akhtarshenas S, Yasini H, Rastegar H. Pharmaceutical Exports of Iran in OIC Region and Entering International Markets. JPPM. 2023;9(3):37-43.
